Solventum has grown revenue 0.79% a year over three years and 0.79% a year over five, with earnings per share compounding at 4.5%. Revenue growth, 3-year annual rate: +0.79% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +0.79%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +4.5%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 4, FY2022 to FY2025, as filed.

SOLVSolventum

Healthcare

$87.38+17% 1Y

$87.38

$62.4952 weeks$92.40

Is it growing?

Good

Growing: earnings up +276% year on year and operating margin widening (+15.5 points).

2 good, 1 neutral

Revenue trend−1% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+276% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+15.5 points operating

Trailing-twelve-month operating margin, 24.8% now against 9.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SOLV growing?

Solventum has grown revenue 0.79% a year over three years and 0.79% a year over five, with earnings per share compounding at 4.5%.

+0.79%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · growing slowly · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +0.79%
Revenue growth, 5-year rate · +0.79% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +4.5%
Earnings per share, 3-year rate · revenue +0.79% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 4
Years of annual history on file · FY2022 to FY2025, as filed